![Applied Therapeutics Inc](/common/images/company/N_APLT.png)
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. Show more
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.085 | -1.60226201697 | 5.305 | 5.44 | 5.01 | 588848 | 5.22405411 | CS |
4 | 0.62 | 13.4782608696 | 4.6 | 6.06 | 4.2699 | 1462393 | 4.93570841 | CS |
12 | 0.59 | 12.7429805616 | 4.63 | 6.06 | 3.95 | 1029525 | 4.74968864 | CS |
26 | 2.31 | 79.381443299 | 2.91 | 9.39 | 2.585 | 1400463 | 5.24667733 | CS |
52 | 3.7 | 243.421052632 | 1.52 | 9.39 | 1.18 | 1267489 | 3.98106066 | CS |
156 | -14.04 | -72.8971962617 | 19.26 | 19.5 | 0.4995 | 617151 | 3.52774346 | CS |
260 | -4.08 | -43.8709677419 | 9.3 | 57.39 | 0.4995 | 424823 | 7.09312167 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.